Biogen Aktie

Kaufen
Verkaufen
139,80 EUR -2,25 EUR -1,58 %
147,37 USD +0,55 USD +0,37 %
Aktien, ETFs, Sparpläne & Kryptos zu Top-Konditionen beim Testsieger von finanztip.de handeln! Du hast schon ein ZERO-Konto? Direkt handeln bei ZERO! Bei einem anderen Broker handeln Smartphone

Marktkap. 20,58 Mrd. EUR

KGV 32,45 Div. Rendite 0,00%

WKN 789617

ISIN US09062X1037

Symbol BIIB


Biogen Aktie Analyse

28.07.11 Biogen buy Jefferies & Company Inc.
27.07.11 Biogen neutral UBS AG
24.06.11 Biogen outperform Credit Suisse Group
26.04.11 Biogen equal-weight Barclays Capital
26.04.11 Biogen outperform RBC Capital Markets
20.04.11 Biogen buy Jefferies & Company Inc.
13.04.11 Biogen neutral Piper Jaffray & Co.
08.04.11 Biogen neutral Credit Suisse Group
30.03.11 Biogen neutral UBS AG
24.02.11 Biogen outperform RBC Capital Markets
09.02.11 Biogen sell Goldman Sachs Group Inc.
03.02.11 Biogen equal-weight Barclays Capital
02.02.11 Biogen neutral Credit Suisse Group
24.01.11 Biogen equal-weight Barclays Capital
20.12.10 Biogen equal-weight Barclays Capital
13.12.10 Biogen equal-weight Barclays Capital
07.12.10 Biogen neutral Credit Suisse Group
17.11.10 Biogen neutral UBS AG
28.10.10 Biogen equal-weight Barclays Capital
28.10.10 Biogen buy Jefferies & Company Inc.
22.10.10 Biogen equal-weight Barclays Capital
19.10.10 Biogen buy Jefferies & Company Inc.
30.09.10 Biogen equal-weight Barclays Capital
23.09.10 Biogen neutral Robert W. Baird & Co. Incorporated
09.09.10 Biogen sell Stifel, Nicolaus & Co., Inc.
26.08.10 Biogen equal-weight Barclays Capital
20.08.10 Biogen equal-weight Barclays Capital
22.07.10 Biogen equal-weight Barclays Capital
20.07.10 Biogen neutral Piper Jaffray & Co.
17.06.10 Biogen halten Barclays Capital
21.04.10 Biogen kaufen Jefferies & Company Inc.
21.04.10 Biogen halten Robert W. Baird & Co. Incorporated
18.02.10 Biogen kaufen Der Aktionär
03.11.09 Biogen buy Jefferies & Company Inc.
26.10.09 Biogen neutral UBS AG
26.10.09 Biogen equal weight Barclays Capital
20.10.09 Biogen sell Brean Murray, Carret & Co., LLC
26.08.09 Biogen market perform William Blair
16.07.09 Biogen sell Brean Murray, Carret & Co., LLC
14.07.09 Biogen outperform Leerink Swann LLC
30.06.09 Biogen neutral Credit Suisse Group
29.06.09 Biogen buy Goldman Sachs Group Inc.
20.05.09 Biogen equal-weight Barclays Capital
11.05.09 Biogen buy Goldman Sachs Group Inc.
27.04.09 Biogen hold Standard & Poor
20.04.09 Biogen underweight Barclays Capital
17.04.09 Biogen neutral Credit Suisse Group
17.04.09 Biogen neutral Robert W. Baird & Co. Incorporated
14.04.09 Biogen neutral Robert W. Baird & Co. Incorporated
07.04.09 Biogen neutral UBS AG